Cholinesterase Inhibitors, Axonal Transport, and Memory

胆碱酯酶抑制剂、轴突运输和记忆

基本信息

  • 批准号:
    7848580
  • 负责人:
  • 金额:
    $ 1.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Organophosphates (OPs) pose a constant threat to human health due to their widespread use as pesticides and their potential employment in terrorist attacks. The acute toxicity of OPs has been extensively studied; however, the consequences of prolonged or repeated exposure to levels of OPs that produce no overt signs of acute toxicity are poorly understood. Further, there is clinical evidence that such low-level exposures to OPs leads to prolonged deficits in cognition, although the mechanism for this effect is unknown. One long- term goal of our laboratories is to elucidate the mechanisms responsible for the prolonged neurobehavioral deficits associated with chronic low-level OP exposures such that more effective therapeutic strategies can be developed. The results of our experiments conducted during the initial funding period established that low- level exposures to the commercial pesticide, chlorpyrifos, resulted in protracted deficits in prepulse inhibition (a model of pre-attentive processing) and spatial learning without significantly affecting locomotor function. Further, chlorpyrifos was associated with decreases in neurotrophin receptors and cholinergic proteins in brain regions that are important to cognitive function. These deficits were accompanied by decreases in axonal transport measured in sciatic nerves ex vivo. However, the molecular mechanisms for the deficits in axonal transport and the extent to which such effects on axonal transport occur in the brain are unclear. The objective of this application is to identify the mechanisms responsible for alterations in axonal transport as well as to further define the long-term effects of low-level OP exposure on cognitive function. Our central hypothesis is that OPs covalently modify key proteins that are involved in axonal transport and that such modifications compromise the function of neuronal pathways that support cognitive function. To achieve our objective, we propose three specific aims: 1) Determine the consequences of chronic low-level exposure to representative OPs on attention and cognitive flexibility, 2) Determine the consequences of chronic low-level exposure to representative OPs on axonal transport in the brain, and 3) Identify the molecular mechanisms responsible for OP-induced deficits in axonal transport. To address these aims, we will use a five choice serial reaction time task to assess sustained attention, a water maze task to measure extinction (a form of cognitive flexibility) and stereotaxic injections of traceable dextrans, immunohistochemistry, and mass spectrometry to determine OP effects on axonal transport in the brain and the consequences of its impairment. The significance of this project and its relevance to public health is that by mechanistically defining OPs based on their long-term effects on essential components of information processing in animals, we will have addressed a fundamental gap in our knowledge of how OPs likely affect humans over time. The experiments will contribute to a better understanding of the toxicity associated with a class of chemicals that continues to pose a significant environmental risk to millions of people worldwide. PUBLIC HEALTH RELEVANCE Organophosphates are highly toxic chemicals that are almost ubiquitous in our environment and, accordingly, they pose a significant health risk to millions of people worldwide. While the acute toxicity of these agents has been extensively studied, the effects of chronic low-level exposures to organophosphates (especially on cognition and the neuronal processes that support cognition) are poorly understood. The experiments proposed in this application have been designed to address these issues in the rodent model by mechanistically defining organophosphates based on their long-term effects on axonal transport (a fundamental process in neurons) and specific domains of cognitive function (i.e., attention and cognitive flexibility).
描述(由申请人提供):有机磷酸盐(OP)由于其作为杀虫剂的广泛使用及其在恐怖袭击中的潜在就业,对人类健康构成持续威胁。对有机磷农药的急性毒性进行了广泛的研究;然而,人们对长期或反复接触不产生明显急性毒性迹象的有机磷农药的后果知之甚少。此外,有临床证据表明,这种低水平的OP暴露会导致认知功能的长期缺陷,尽管这种影响的机制尚不清楚。我们实验室的一个长期目标是阐明与慢性低水平OP暴露相关的长期神经行为缺陷的机制,以便开发更有效的治疗策略。我们在最初资助期间进行的实验结果表明,低水平暴露于商业杀虫剂毒死蜱,导致前脉冲抑制(前注意处理模型)和空间学习的长期缺陷,而不会显著影响运动功能。此外,毒死蜱与大脑区域中对认知功能至关重要的神经营养素受体和胆碱能蛋白的减少有关。这些赤字伴随着减少轴突运输测量坐骨神经离体。然而,轴突运输缺陷的分子机制和轴突运输的影响在脑中发生的程度尚不清楚。本申请的目的是确定轴突运输改变的机制,并进一步确定低水平OP暴露对认知功能的长期影响。我们的中心假设是,OP共价修饰参与轴突运输的关键蛋白质,这种修饰损害了支持认知功能的神经元通路的功能。为了实现我们的目标,我们提出了三个具体目标:1)确定长期低水平暴露于代表性OP对注意力和认知灵活性的影响,2)确定长期低水平暴露于代表性OP对大脑轴突运输的影响,3)确定OP诱导轴突运输缺陷的分子机制。为了实现这些目标,我们将使用五个选择的连续反应时间任务来评估持续的注意力,水迷宫任务来测量灭绝(认知灵活性的一种形式)和可追踪的葡聚糖,免疫组织化学和质谱的立体定位注射,以确定OP对大脑轴突运输的影响及其损害的后果。该项目的意义及其与公共卫生的相关性在于,通过基于其对动物信息处理的重要组成部分的长期影响来机械地定义OP,我们将解决我们对OP如何随着时间的推移影响人类的知识的根本差距。这些实验将有助于更好地了解一类化学品的毒性,这些化学品继续对全世界数百万人构成重大环境风险。有机磷酸盐是剧毒化学品,在我们的环境中几乎无处不在,因此,它们对全球数百万人的健康构成重大风险。虽然对这些制剂的急性毒性进行了广泛研究,但对长期低水平接触有机磷的影响(特别是对认知和支持认知的神经元过程的影响)了解甚少。本申请中提出的实验已经被设计为通过基于有机磷酸酯对轴突运输(神经元中的基本过程)和认知功能的特定领域(即,注意力和认知灵活性)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALVIN V TERRY其他文献

ALVIN V TERRY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALVIN V TERRY', 18)}}的其他基金

Renovation of the cage wash facility at the MCG animal facility in Gracewood, GA
乔治亚州 Gracewood 的 MCG 动物设施的笼子清洗设施翻新
  • 批准号:
    8184269
  • 财政年份:
    2012
  • 资助金额:
    $ 1.71万
  • 项目类别:
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse
治疗与滥用药物相关的认知障碍的药物发现
  • 批准号:
    8049641
  • 财政年份:
    2010
  • 资助金额:
    $ 1.71万
  • 项目类别:
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse
治疗与滥用药物相关的认知障碍的药物发现
  • 批准号:
    8434271
  • 财政年份:
    2010
  • 资助金额:
    $ 1.71万
  • 项目类别:
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse
治疗与滥用药物相关的认知障碍的药物发现
  • 批准号:
    8616366
  • 财政年份:
    2010
  • 资助金额:
    $ 1.71万
  • 项目类别:
Drug Discovery for Cognitive Impairment Associated with Drugs of Abuse
治疗与滥用药物相关的认知障碍的药物发现
  • 批准号:
    8233427
  • 财政年份:
    2010
  • 资助金额:
    $ 1.71万
  • 项目类别:
Procognitive and Antipsychotic Actions of JWS-USC-75-IX
JWS-USC-75-IX 的认知和抗精神病作用
  • 批准号:
    7531871
  • 财政年份:
    2008
  • 资助金额:
    $ 1.71万
  • 项目类别:
Procognitive and Antipsychotic Actions of JWS-USC-75-IX
JWS-USC-75-IX 的认知和抗精神病作用
  • 批准号:
    7661569
  • 财政年份:
    2008
  • 资助金额:
    $ 1.71万
  • 项目类别:
Cotinine for Cognitive Impairment in Neurological and Neuropsychiatric Disorders
可替宁治疗神经和神经精神疾病的认知障碍
  • 批准号:
    7874475
  • 财政年份:
    2007
  • 资助金额:
    $ 1.71万
  • 项目类别:
Cotinine for Cognitive Impairment in Neurological and Neuropsychiatric Disorders
可替宁治疗神经和神经精神疾病的认知障碍
  • 批准号:
    7643136
  • 财政年份:
    2007
  • 资助金额:
    $ 1.71万
  • 项目类别:
Antipsychotics: Temporal Effects on Cognitive Function
抗精神病药:对认知功能的时间影响
  • 批准号:
    6857149
  • 财政年份:
    2003
  • 资助金额:
    $ 1.71万
  • 项目类别:

相似海外基金

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
  • 批准号:
    10739853
  • 财政年份:
    2023
  • 资助金额:
    $ 1.71万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10772738
  • 财政年份:
    2023
  • 资助金额:
    $ 1.71万
  • 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
  • 批准号:
    10378934
  • 财政年份:
    2021
  • 资助金额:
    $ 1.71万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10303546
  • 财政年份:
    2021
  • 资助金额:
    $ 1.71万
  • 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
  • 批准号:
    2480200
  • 财政年份:
    2020
  • 资助金额:
    $ 1.71万
  • 项目类别:
    Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    9977281
  • 财政年份:
    2019
  • 资助金额:
    $ 1.71万
  • 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    10238898
  • 财政年份:
    2019
  • 资助金额:
    $ 1.71万
  • 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
  • 批准号:
    18K15850
  • 财政年份:
    2018
  • 资助金额:
    $ 1.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
  • 批准号:
    481759-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 1.71万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
  • 批准号:
    8735550
  • 财政年份:
    2014
  • 资助金额:
    $ 1.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了